Bioceltix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of XI3?
Owner TypeNumber of SharesOwnership Percentage
Private Companies256,8325.22%
Individual Insiders365,7637.43%
VC/PE Firms470,9539.56%
Institutions908,92918.5%
General Public2,921,99159.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.3%.


Top Shareholders

Top 10 shareholders own 40.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.56%
Kvarko ASI Sp. z o. o.
470,953€8.4m0%no data
7.51%
IPOPEMA Towarzystwo Funduszy Inwestycyjnych SA
370,000€6.6m0%5.11%
7.43%
Lukasz Bzdzion
365,763€6.5m0%no data
5.22%
Alternative Solution Alternatywna Spolka Inwestycyjna Spolka Akcyjna
256,832€4.6m0%no data
4.2%
Esaliens TFI S.A.
206,939€3.7m0%0.92%
3.89%
Towarzystwo Funduszy Inwestycyjnych PZU SA
191,529€3.4m0%0.21%
2.09%
Norges Bank Investment Management
102,892€1.8m0%no data
0.36%
Union Investment TFI S.A
17,848€319.1k0%0.08%
0.24%
Goldman Sachs Asset Management, L.P.
12,000€214.5k0%no data
0.16%
AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A.
7,721€138.0k0%0.03%